Essex Investment Management’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-24,946
Closed -$951K 407
2022
Q3
$951K Buy
24,946
+711
+3% +$35.6K 0.15% 200
2022
Q2
$1.32M Buy
24,235
+820
+4% +$45.1K 0.21% 140
2022
Q1
$1.46M Buy
23,415
+1,084
+5% +$71.4K 0.18% 177
2021
Q4
$2.25M Buy
22,331
+1,728
+8% +$152K 0.26% 127
2021
Q3
$1.85M Sell
20,603
-131
-0.6% -$11.9K 0.23% 152
2021
Q2
$1.91M Buy
20,734
+7,800
+60% +$623K 0.22% 152
2021
Q1
$1.25M Sell
12,934
-45,886
-78% -$4.74M 0.15% 212
2020
Q4
$3.06M Sell
58,820
-29,012
-33% -$1.21M 0.38% 83
2020
Q3
$3.52M Sell
87,832
-77,431
-47% -$2.42M 0.5% 46
2020
Q2
$2.64M Sell
165,263
-656
-0.4% -$10K 0.43% 69
2020
Q1
$1.78M Sell
165,919
-47,138
-22% -$657K 0.36% 81
2019
Q4
$2.75M Buy
213,057
+90,415
+74% +$1.07M 0.34% 87
2019
Q3
$1.27M Sell
122,642
-32,159
-21% -$305K 0.18% 178
2019
Q2
$1.03M Buy
154,801
+64,573
+72% +$393K 0.14% 219
2019
Q1
$537K Buy
90,228
+7,747
+9% +$35.5K 0.08% 256
2018
Q4
$261K Buy
+82,481
New +$290K 0.04% 308

Other funds holding FLGT

Essex Investment Management's FLGT Position: Q4 2022 in Review

Essex Investment Management sold out of Fulgent Genetics (FLGT) in Q4 2022, closing a stake of 24,946 shares — an estimated $951K sold.

Essex Investment Management first reported a position in FLGT in Q4 2018 and held it in 16 quarters. The position peaked at $3.52M in Q3 2020. 224 funds tracked by Wall St. Rank hold FLGT as of Q4 2022.

  • Essex Investment Management reported no remaining Fulgent Genetics position as of Q4 2022 after selling out during the quarter.
  • Essex Investment Management sold 24,946 Fulgent Genetics shares in Q4 2022, an estimated $951K.
  • Essex Investment Management first reported a position in Fulgent Genetics in Q4 2018 and held it in 16 quarters.
  • Essex Investment Management's Fulgent Genetics position peaked at $3.52M in Q3 2020.
  • 224 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2022.

Based on Essex Investment Management's 13F filing for Q4 2022, filed 3 Feb 2023.